DoW, Ovarian Cancer, Pilot Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- May 4, 2026
- Amount
- Program total $4.6M
- Closes
- Oct 1, 2026 (in 15 days)
Similar opportunities open now
- DoW, Ovarian Cancer, Investigator-Initiated Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW Ovarian Cancer, Clinical Trial AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW, Ovarian Cancer, Ovarian Cancer Academy – Early-Career Investigator AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 15 days
- DoW Pancreatic Cancer Research Program, Focused Pilot AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 21 days
- DoW, Peer Reviewed Cancer, Impact AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 19 days
Classification and identifiers
- Solicitation number
- HT942526OCRPPA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $4.6M
Who can apply
About this opportunity
Summary: The Ovarian Cancer Pilot Award supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead to critical discoveries or major advancements that will drive the field forward. Distinctive Features: Innovation is key. Research projects that demonstrate exceptional scientific merit but lack innovation do not meet the intent of the mechanism. Preliminary data are not required but are allowed for this mechanism. This mechanism includes a blinded pre-application component. Pre-applications to this funding opportunity will undergo a blinded pre-application screening. While preparing your pre-application, do not include any material that may identify the PI, a col...